Results 131 to 140 of about 21,287 (236)

ADPKD

open access: yes, 2017
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease and is characterized by progressive cyst formation in both kidneys and renal function loss. It is the fourth most common cause of end-stage renal disease for which renal replacement therapy has to be started.
openaire   +1 more source

Subgroup Analysis of ADPKD with and without radiologic bronchiectasis.

open access: yes, 2014
Subgroup Analysis of ADPKD with and without radiologic bronchiectasis.
Ladan Zand (583025)   +6 more
core   +1 more source

The Relationship of Renalase with Diurnal Blood Pressure Rhythm, Left Ventricular Mass Index and Carotid Intima–media Thickness in Autosomal Dominant Polycystic Kidney Disease

open access: yesSaudi Journal of Kidney Diseases and Transplantation
This study investigated the relationship between renalase and diurnal blood pressure (BP) rhythm, left ventricular mass index (LVMI) and carotid intima-media thickness (IMT) in autosomal dominant polycstic kidney disease (ADPKD) patients.
Veysel Erol   +9 more
doaj   +1 more source

Summary of the pathogenic mutations in Japanese patients with ADPKD.

open access: yes, 2016
Summary of the pathogenic mutations in Japanese patients with ADPKD.
Kimiyoshi Sudo (3343949)   +15 more
core   +1 more source

Frailty Among Patients With ADPKD

open access: yesKidney International Reports
Autosomal dominant polycystic kidney disease (ADPKD) is a major inherited cause of end-stage kidney disease (ESKD), associated with various systemic complications. Frailty, a degenerative condition linked to adverse health outcomes, may be influenced by ADPKD and its complications; however, data on this association is limited.
Wang, Jui   +6 more
openaire   +2 more sources

Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease

open access: yesKidney Medicine
Rationale & Objective: Using OVERTURE (NCT01430494) study data on patient-perceived health, health care utilization, and productivity in autosomal dominant polycystic kidney disease (ADPKD), this research was conducted to characterize the burden of ...
Dorothee Oberdhan   +3 more
doaj   +1 more source

Renal denervation in ADPKD: an exceptional case

open access: yes, 2014
Sympathetic overactivity plays a crucial role in the genesis and aggravation of arterial hypertension in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Marchetiello Cristina   +6 more
core  

End Point Selection in ADPKD Clinical Trials

open access: yesKidney International Reports
Autosomal dominant polycystic kidney disease (ADPKD) is the leading hereditary cause of kidney failure. Challenges have arisen in developing consensus-based clinical trial end points endorsed by the wider ADPKD research community and regulators.
Kitty St Pierre   +7 more
doaj   +1 more source

Impacts of Metabolic and Mitochondrial Reprogramming on ADPKD Drug Targets and Repurposing

open access: yes
Autosomal dominant polycystic kidney disease (ADPKD) is a complex disorder characterized by the progressive development of renal cysts. Disease progression is linked to ADPKD-driven metabolic and mitochondrial reprogramming that exacerbates ADPKD ...
Phillip H. Chumley   +6 more
core   +1 more source

Repurposing calcium-sensing receptor activator drug cinacalcet for ADPKD treatment.

open access: yes
ADPKD is characterized by progressive cyst formation and enlargement leading to kidney failure. Tolvaptan is currently the only FDA-approved treatment for ADPKD; however, it can cause serious adverse effects including hepatotoxicity.
Chhetri, Parth   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy